相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Renal cell carcinoma therapy: Current and new drug candidates
Olivia Pontes et al.
DRUG DISCOVERY TODAY (2022)
Inositol depletion regulates phospholipid metabolism and activates stress signaling in HEK293T cells
Mahmoud Suliman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2022)
ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma
T. Powles et al.
ANNALS OF ONCOLOGY (2021)
Reactive oxygen species (ROS) in cancer pathogenesis and therapy: An update on the role of ROS in anticancer action of benzophenanthridine alkaloids
Abdul Q. Khan et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma
Tomonori Sato et al.
METABOLITES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Crizotinib and Sunitinib Induce Hepatotoxicity and Mitochondrial Apoptosis in L02 Cells via ROS and Nrf2 Signaling Pathway
Lin Guo et al.
FRONTIERS IN PHARMACOLOGY (2021)
Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells
Magdalena Rausch et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
ROS in cancer therapy: the bright side of the moon
Bruno Perillo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Immunotherapy in Renal Cell Carcinoma: The Future Is Now
Antoine Deleuze et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy
Charles Pottier et al.
CANCERS (2020)
Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine
Richard D. Beger et al.
METABOLITES (2020)
Epidemiology of Renal Cell Carcinoma
Sandeep Anand Padala et al.
WORLD JOURNAL OF ONCOLOGY (2020)
Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?
Gokhan Ucar et al.
CUREUS (2020)
A metabolomic perspective of pazopanib-induced acute hepatotoxicity in mice
Yi-Kun Wang et al.
XENOBIOTICA (2019)
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B. Escudier et al.
ANNALS OF ONCOLOGY (2019)
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update
Borje Ljungberg et al.
EUROPEAN UROLOGY (2019)
Multiomic Profiling of Tyrosine Kinase Inhibitor-Resistant K562 Cells Suggests Metabolic Reprogramming To Promote Cell Survival
Brett M. Noel et al.
JOURNAL OF PROTEOME RESEARCH (2019)
Pazopanib has equivalent anti-tumor effectiveness and lower Total costs than Sunitinib for treating metastatic or advanced renal cell carcinoma: a meta-analysis
Huan Deng et al.
BMC CANCER (2019)
A strategy for early detection of response to chemotherapy drugs based on treatment-related changes in the metabolome
Shahil Amin et al.
PLOS ONE (2019)
Mitochondrial oxidative stress plays a critical role in the cardiotoxicity of sunitinib Running title: Sunitinib and oxidative stress in hearts
Jamal Bouitbir et al.
TOXICOLOGY (2019)
Myo-Inositol and Its Derivatives: Their Emerging Role in the Treatment of Human Diseases
Dhani Raj Chhetri
FRONTIERS IN PHARMACOLOGY (2019)
Investigation of Metabolomic Changes in Sunitinib-Resistant Human Renal Carcinoma 786-O Cells by Capillary Electrophoresis-Time of Flight Mass Spectrometry
Hiroto Hatakeyama et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2018)
Glutathione metabolism in cancer progression and treatment resistance
Ankita Bansal et al.
JOURNAL OF CELL BIOLOGY (2018)
The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer
Michaela Poliakova et al.
MOLECULAR CANCER (2018)
The role of cellular reactive oxygen species in cancer chemotherapy
Haotian Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
A Metabolomics Approach to Pharmacotherapy Personalization
Elena E. Balashova et al.
JOURNAL OF PERSONALIZED MEDICINE (2018)
NMRProcFlow: a graphical and interactive tool dedicated to 1D spectra processing for NMR- based metabolomics
D. Jacob et al.
METABOLOMICS (2017)
Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
Hanna-Riikka Teppo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Strategies to over come therapeutic resistance in renal cell carcinoma
Peter J. Siska et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis
Franziska Paech et al.
FRONTIERS IN PHARMACOLOGY (2017)
Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach
Jodi Rattner et al.
METABOLITES (2017)
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities
Nathan J. Lanning et al.
CANCER & METABOLISM (2017)
3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions
Maria Joao Valente et al.
ARCHIVES OF TOXICOLOGY (2016)
Tissue metabolic profiling of human gastric cancer assessed by 1H NMR
Huijuan Wang et al.
BMC CANCER (2016)
Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes
Emmanuel I. Papadopoulos et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Liver enzymes, metabolomics and genome-wide association studies: From systems biology to the personalized medicine
Silvia Sookoian et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Genetic variants in the inositol phosphate metabolism pathway and risk of different types of cancer
Juan Tan et al.
SCIENTIFIC REPORTS (2015)
Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs. Sorafenib-Everolimus Combination Therapy
Ji-xiang Zhang
MEDICAL SCIENCE MONITOR (2015)
The Potential Role of Lysosomal Sequestration in Sunitinib Resistance of Renal Cell Cancer
Kaamar Azijli et al.
JOURNAL OF KIDNEY CANCER AND VHL (2015)
Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma
A. B. Suttle et al.
BRITISH JOURNAL OF CANCER (2014)
Epidermal Growth Factor Receptor ( EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma
Hideki Makinoshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells
M. Santoni et al.
BRITISH JOURNAL OF CANCER (2013)
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
An indirect comparison of the toxicity of sunitinib and pazopanib in metastatic clear cell renal cancer
Thomas Powles et al.
EUROPEAN JOURNAL OF CANCER (2012)
Effect size estimation: Methods and examples
Lut Berben et al.
INTERNATIONAL JOURNAL OF NURSING STUDIES (2012)
Sunitinib and other targeted therapies for renal cell carcinoma
T. Powles et al.
BRITISH JOURNAL OF CANCER (2011)
Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
Kristy J. Gotink et al.
CLINICAL CANCER RESEARCH (2011)
Magnetic Resonance Spectroscopy Detectable Metabolomic Fingerprint of Response to Antineoplastic Treatment
Alessia Lodi et al.
PLOS ONE (2011)
Improved parametric time warping for proteomics
Tom G. Bloemberg et al.
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS (2010)
Autophagy plays an important role in Sunitinib-mediated cell death in H9c2 cardiac muscle cells
Yuqin Zhao et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
A direct cell quenching method for cell-culture based metabolomics
Quincy Teng et al.
METABOLOMICS (2009)
Cancer cell killing via ROS To increase or decrease, that is the question
Jie Wang et al.
CANCER BIOLOGY & THERAPY (2008)
BioMagResBank
Eldon L. Ulrich et al.
NUCLEIC ACIDS RESEARCH (2008)